Health-related quality of life and economic burden of chronic lymphocytic leukemia in the era of novel targeted agents-Reference-Cited by-同舟云学术

Health-related quality of life and economic burden of chronic lymphocytic leukemia in the era of novel targeted agents

Published:2020-07-23 Issue:9 Volume:36 Page:1481-1495
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Waweru Catherine¹,Kaur Simarjeet²,Sharma Sheetal²,Mishra Namita²

Affiliation:

1. Health Economics, AstraZeneca, Gaithersburg, MD, USA

2. Parexel Access Consulting, Parexel International, Mohali, India

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2020.1784120

Reference57 articles.

1. Orphanet Report Series. Prevalence and incidence of rare diseases: bibliographic data. [cited 2019 Sep 18]. Available from: https://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf.

2. SEER. Cancer Stat Facts: NHL – chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). [cited 2019 Oct 29]. Available from: https://seer.cancer.gov/statfacts/html/cllsll.html

3. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

4. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Lymphocytic Leukemia: Time to Care for the Survivors;Journal of Clinical Oncology;2024-06-10

4. Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study;Hematological Oncology;2023-09-29

5. Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region;Acta Haematologica;2023-09-26